Multifunctional Ebselen drug functions through the activation of DNA damage response and alterations in nuclear proteins

Biochemical Pharmacology

Volumn 83, Issue 2, 2012, Pages 296-303

  Azad, Gajendra K ^a   Balkrishna, Shah Jaimin ^a   Sathish, Narayanan ^a   Kumar, Sangit ^a   Tomar, Raghuvir S ^a  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

Author keywords

Chromatin; DNA damage response; Ebselen; Post translational modifications

Indexed keywords

EBSELEN; HISTONE H3; HYDROXYUREA; LYSINE; MESYLIC ACID; NUCLEAR PROTEIN; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG MECHANISM; GROWTH DISORDER; HISTONE MODIFICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; YEAST CELL;

ANTIOXIDANTS; AZOLES; DNA DAMAGE; NUCLEAR PROTEINS; ORGANOSELENIUM COMPOUNDS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 83955161230     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.10.011     Document Type: Article

References (59)

1. M.G. Belvisi, E.B. Haddad, C. Battram, M. Birrell, M. Foster, and S. Webber Anti-inflammatory properties of Ebselen in a model of sephadex-induced lung inflammation Eur Respir J 15 3 2000 579 581 (Pubitemid 30158199)
2. C.F. Yang, H.M. Shen, and C.N. Ong Protective effect of Ebselen against hydrogen peroxide-induced cytotoxicity and DNA damage in HepG2 cells Biochem Pharmacol 57 3 1999 273 279
3. C.F. Yang, J. Liu, H.M. Shen, and C.N. Ong Protective effect of Ebselen on aflatoxin B1-induced cytotoxicity in primary rat hepatocytes Pharmacol Toxicol 86 4 2000 156 161 (Pubitemid 30205183)
4. S. Hoshida, K. Aoki, M. Nishida, N. Yamashita, J. Igarashi, and M. Hori Effects of preconditioning with Ebselen on glutathione metabolism and stress protein expression J Pharmacol Exp Ther 281 3 1997 1471 1475 (Pubitemid 27258409)
5. I. Saito, T. Asano, K. Sano, K. Takakura, H. Abe, and T. Yoshimoto Neuroprotective effect of an antioxidant, Ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage Neurosurgery 42 2 1998 269 277 (discussion 77-78)
6. K. Yamagata, S. Ichinose, A. Miyashita, and M. Tagami Protective effects of Ebselen, a seleno-organic antioxidant on neurodegeneration induced by hypoxia and reperfusion in stroke-prone spontaneously hypertensive rat Neuroscience 153 2 2008 428 435
7. T. Posser, M.P. Kaster, S.C. Barauna, J.B. Rocha, A.L. Rodrigues, and R.B. Leal Antidepressant-like effect of the organoselenium compound Ebselen in mice: evidence for the involvement of the monoaminergic system Eur J Pharmacol 602 1 2009 85 91
8. M. Ozaki, M. Nakamura, S. Teraoka, and K. Ota Ebselen, a novel anti-oxidant compound, protects the rat liver from ischemia-reperfusion injury Transpl Int 10 2 1997 96 102 (Pubitemid 27110497)
9. W. Beil, U. Staar, and K.F. Sewing Interaction of the anti-inflammatory seleno-organic compound Ebselen with acid secretion in isolated parietal cells and gastric H+/K(+)-ATPase Biochem Pharmacol 40 9 1990 1997 2003 (Pubitemid 20346450)
10. C.F. Yang, H.M. Shen, and C.N. Ong Ebselen induces apoptosis in HepG(2) cells through rapid depletion of intracellular thiols Arch Biochem Biophys 374 2 2000 142 152
11. T.H. Lugokenski, L.G. Muller, P.S. Taube, J.B. Rocha, and M.E. Pereira Inhibitory effect of Ebselen on lactate dehydrogenase activity from mammals: a comparative study with diphenyl diselenide and diphenyl ditelluride Drug Chem Toxicol 34 1 2011 66 76
12. M.J. Parnham, and S. Kindt A novel biologically active seleno-organic compound - III. Effects of PZ 51 (Ebselen) on glutathione peroxidase and secretory activities of mouse macrophages Biochem Pharmacol 33 20 1984 3247 3250 (Pubitemid 14023259)
13. A. Batna, C. Fuchs, and G. Spiteller Lipid peroxidation in presence of Ebselen Chem Phys Lipids 87 2 1997 149 158 (Pubitemid 27361990)
14. O.I. Aruoma Scavenging of hypochlorous acid by carvedilol and Ebselen in vitro Gen Pharmacol 28 2 1997 269 272 (Pubitemid 27016137)
15. A. Muller, E. Cadenas, P. Graf, and H. Sies A novel biologically active seleno-organic compound - I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen) Biochem Pharmacol 33 20 1984 3235 3239 (Pubitemid 14023257)
16. Y. Nakamura, Q. Feng, T. Kumagai, K. Torikai, H. Ohigashi, and T. Osawa Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. Implication for inflammation-associated carcinogenesis J Biol Chem 277 4 2002 2687 2694 (Pubitemid 34953296)
17. A. Li, J.M. Eirin-Lopez, and J. Ausio H2AX: tailoring histone H2A for chromatin-dependent genomic integrity Biochem Cell Biol 83 4 2005 505 515 (Pubitemid 41626769)
18. C. Featherstone, and S.P. Jackson DNA-dependent protein kinase gets a break: its role in repairing DNA and maintaining genomic integrity Br J Cancer 80 Suppl. 1 1999 14 19 (Pubitemid 29389601)
19. L. Hartwell, T. Weinert, L. Kadyk, and B. Garvik Cell cycle checkpoints, genomic integrity, and cancer Cold Spring Harb Symp Quant Biol 59 1994 259 263
20. J.L. Tarry-Adkins, and S.E. Ozanne Mechanisms of early life programming: current knowledge and future directions Am J Clin Nutr 2011
21. D. Bayarsaihan Epigenetic mechanisms in inflammation J Dent Res 90 1 2011 9 17
22. R. Woroniecki, A.B. Gaikwad, and K. Susztak Fetal environment, epigenetics, and pediatric renal disease Pediatr Nephrol 26 5 2011 705 711 PMCID: 3063864
23. P.V. Licciardi, S.S. Wong, M.L. Tang, and T.C. Karagiannis Epigenome targeting by probiotic metabolites Gut Pathog 2 1 2010 24 PMCID: 3016256
24. Z. Gao, and C.W. Xu Glucose metabolism induces mono-ubiquitination of histone H2B in mammalian cells Biochem Biophys Res Commun 404 1 2011 428 433
25. M. Fanelli, S. Amatori, I. Barozzi, M. Soncini, R. Dal Zuffo, and G. Bucci Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples Proc Natl Acad Sci USA 107 50 2010 21535 21540 PMCID: 3003125
26. M. Berdasco, and M. Esteller Aberrant epigenetic landscape in cancer: how cellular identity goes awry Dev Cell 19 5 2010 698 711
27. J.L. Larson, and G.C. Yuan Epigenetic domains found in mouse embryonic stem cells via a hidden Markov model BMC Bioinformatics 11 2010 557 PMCID: 2992069
28. G.C. Burdge, and K.A. Lillycrop Bridging the gap between epigenetics research and nutritional public health interventions Genome Med 2 11 2010 80 PMCID: 3016622
29. J.B. Marteau, O. Rigaud, T. Brugat, N. Gault, L. Vallat, and M. Kruhoffer Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males BMC Med Genomics 3 2010 53 PMCID: 2994775
30. X.F. Xu, and L.Z. Du Epigenetics in neonatal diseases Chin Med J (Engl) 123 20 2010 2948 2954
31. J. Lee, and H. Ryu Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker? BMB Rep 43 10 2010 649 655
32. S.L. McGee, and M. Hargreaves Histone modifications and exercise adaptations J Appl Physiol 110 1 2011 258 263
33. B.S. Atanassov, E. Koutelou, and S.Y. Dent The role of deubiquitinating enzymes in chromatin regulation FEBS Lett 2010 PMCID: 3036772
34. G. Rumbaugh, and C.A. Miller Epigenetic changes in the brain: measuring global histone modifications Methods Mol Biol 670 2011 263 274
35. R.M. Rivera, and L.B. Bennett Epigenetics in humans: an overview Curr Opin Endocrinol Diabetes Obes 17 6 2010 493 499
36. F.G. Osorio, I. Varela, E. Lara, X.S. Puente, J. Espada, and R. Santoro Nuclear envelope alterations generate an aging-like epigenetic pattern in mice deficient in Zmpste24 metalloprotease Aging Cell 9 6 2010 947 957
37. R. Taby, and J.P. Issa Cancer epigenetics CA Cancer J Clin 60 6 2010 376 392
38. A.P. Feinberg Epigenetics at the epicenter of modern medicine JAMA 299 11 2008 1345 1350 (Pubitemid 351439080)
39. Y. Yuasa Frontiers in epigenetics medicine: foreword: miniseries assembled from a symposium organized by the Study Group on Epigenetics Medicine held at the 77th Annual Meeting of the Japanese Society for Hygiene, 2007 Environ Health Prev Med 13 1 2008 2 PMCID: 2698242
40. S. Iraola-Guzman, X. Estivill, and R. Rabionet DNA methylation in neurodegenerative disorders: a missing link between genome and environment? Clin Genet 2011
41. J.M. Salbaum, and C. Kappen Diabetic embryopathy: a role for the epigenome? Birth Defects Res A Clin Mol Teratol 2011
42. I.K. Sundar, N. Mullapudi, H. Yao, S.D. Spivack, and I. Rahman Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics Curr Opin Pulm Med 2011
43. M.L. North, and A.K. Ellis The role of epigenetics in the developmental origins of allergic disease Ann Allergy Asthma Immunol 106 5 2011 355 361
44. M.J. Jardim microRNAs: implications for air pollution research Mutat Res 2011
45. R.F. Luco, and T. Misteli More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation Curr Opin Genet Dev 2011
46. H. van Bokhoven, and J.M. Kramer Disruption of the epigenetic code: an emerging mechanism in mental retardation Neurobiol Dis 39 1 2010 3 12
47. A.D. Goldberg, L.A. Banaszynski, K.M. Noh, P.W. Lewis, S.J. Elsaesser, and S. Stadler Distinct factors control histone variant H3.3 localization at specific genomic regions Cell 140 5 2010 678 691 PMCID: 2885838
48. P. Scaffidi, and T. Misteli Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells Cold Spring Harb Symp Quant Biol 2010
49. S.J. Balkrishna, B.S. Bhakuni, D. Chopra, and S. Kumar Cu-catalyzed efficient synthetic methodology for Ebselen and related Se-N heterocycles Org Lett 12 23 2010 5394 5397
50. M. Oshita, Y. Takei, S. Kawano, H. Fusamoto, and T. Kamada Protective effect of Ebselen on constrictive hepatic vasculature: prevention of alcohol-induced effects on portal pressure in perfused livers J Pharmacol Exp Ther 271 1 1994 20 24 (Pubitemid 24333108)
51. T. Schewe Molecular actions of Ebselen - an antiinflammatory antioxidant Gen Pharmacol 26 6 1995 1153 1169
52. K.P. Bhabak, and G. Mugesh Synthesis, characterization, and antioxidant activity of some Ebselen analogues Chemistry 13 16 2007 4594 4601 (Pubitemid 46925566)
53. R.K. Vempati DNA damage in the presence of chemical genotoxic agents induce acetylation of H3K56 and H4K16 but not H3K9 in mammalian cells Mol Biol Rep 2011
54. J. Schneider, P. Bajwa, F.C. Johnson, S.R. Bhaumik, and A. Shilatifard Rtt109 is required for proper H3K56 acetylation: a chromatin mark associated with the elongating RNA polymerase II J Biol Chem 281 49 2006 37270 37274 (Pubitemid 46042030)
55. S.J. Elledge, and R.W. Davis DNA damage induction of ribonucleotide reductase Mol Cell Biol 9 11 1989 4932 4940 PMCID: 363644 (Pubitemid 19275963)
56. X. Zhao, and R. Rothstein The Dun1 checkpoint kinase phosphorylates and regulates the ribonucleotide reductase inhibitor Sml1 Proc Natl Acad Sci USA 99 6 2002 3746 3751 PMCID: 122595 (Pubitemid 34252177)
57. A. Chabes, V. Domkin, and L. Thelander Yeast Sml1, a protein inhibitor of ribonucleotide reductase J Biol Chem 274 51 1999 36679 36683
58. X. Zhao, A. Chabes, V. Domkin, L. Thelander, and R. Rothstein The ribonucleotide reductase inhibitor Sml1 is a new target of the Mec1/Rad53 kinase cascade during growth and in response to DNA damage EMBO J 20 13 2001 3544 3553 PMCID: 125510 (Pubitemid 32634361)
59. B.L. Andreson, A. Gupta, B.P. Georgieva, and R. Rothstein The ribonucleotide reductase inhibitor Sml1, is sequentially phosphorylated, ubiquitylated and degraded in response to DNA damage Nucleic Acids Res 38 19 2010 6490 6501 PMCID: 2965251